Serum uric acid levels and long-term outcomes in chronic kidney disease

Heart and Vessels

Volumn 29, Issue 4, 2014, Pages 504-512

  Miyaoka, Tokiko ^a   Mochizuki, Toshio ^a   Takei, Takashi ^a   Tsuchiya, Ken ^a   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

All cause mortality; Allopurinol; Cardiovascular mortality; End stage renal disease; Hyperuricemia; Predictor

Indexed keywords

ALLOPURINOL; URIC ACID; ANTIGOUT AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICEMIA; JAPANESE (PEOPLE); KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL; VERY ELDERLY; BLOOD; CAUSE OF DEATH; EPIDEMIOLOGY; JAPAN; KIDNEY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; ALLOPURINOL; BIOLOGICAL MARKERS; CAUSE OF DEATH; FEMALE; GLOMERULAR FILTRATION RATE; GOUT SUPPRESSANTS; HUMANS; HYPERURICEMIA; JAPAN; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; URIC ACID;

EID: 84904104295     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-013-0396-0     Document Type: Article

References (28)

1. Saito T, Mochizuki T, Uchida K, Tsuchiya K, Nitta K (2013) Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan. Heart Vessels 28:323-329
2. Nishino M, Mori N, Yoshimura T, Nakamura D, Lee Y, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y (2013) Higher serum uric acid and lipoprotein (a) are correlated with coronary spasm. Heart Vessels. doi:10.1007/s00380-013-0346-x
3. Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JK, Fried LF (2007) Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 50:239-247 (Pubitemid 47095076)
4. Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811-1821
5. Navaneethan SD, Beddhu S (2009) Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrol Dial Transpl 24:1260-1266
6. Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular and death: the Framingham Heart Study. Ann Intern Med 131:7-13 (Pubitemid 29310011)
7. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD (2000) Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 10:136-143 (Pubitemid 30171270)
8. Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA (2011) Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider. Am J Kidney Dis 58:398-408
9. Kusano E (2011) Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon. Clin Exp Nephrol 15:627-633
10. Berger L, Yu T (1975) Renal function in gout: an analysis of 524 gouty subjects including long-term follow-up studies. Am J Med 59:605-613
11. Beck L (1986) Requiem for gouty nephropathy. Kidney Int 30:280-287
12. Syrjanen J, Mustonen J, Pasternak A (2000) Hypertriglyceridemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 15:34-42 (Pubitemid 30037928)
13. Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, Hikita M (2001) Serum uric acid and renal prognosis in IgA nephropathy. Nephron 87:333-339 (Pubitemid 32260834)
14. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S (2001) Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 24:691-697 (Pubitemid 33133783)
15. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44:642-650 (Pubitemid 39237608)
16. Yamashita T, Yoshida T, Ogawa T, Tsuchiya K, Nitta K (2011) Clinical outcomes in patients with chronic kidney disease: 1 5-year retrospective cohort study at a University Hospital in Japan. Clin Exp Nephrol 15:831-840
17. Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A (2010) Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol 14:558-570
18. Yamanaka H, Japanese Society of Gout and Nucleic Acid Metabolism (2011) Japanese guideline for the management of hyperuricemia and gout: second edition. Nuceosides Nucleotides Nucleic Acids 30:1018-1029
19. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS (2008) Uric acid and incident kidney disease in the community. J Am Soc Nephrol 19:1204-1211
20. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V (2009) Uric acid and long-term outcomes in CKD. Am J Kidney Dis 53:796-803
21. Siu YP, Leung KT, Tong MK, Kwan TH (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47:51-59 (Pubitemid 41828266)
22. Suliman ME, Johnson RJ, Garcia-Lopez E, Wureshi AR, Molinaei H, Carrero JJ, Heimburger O, Barany P, Axelsson J, Lindholm B, Steinvinkel P (2006) J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis 48:761-771 (Pubitemid 44740052)
23. Sturm G, Kolleritis B, Neyer U, Ritz E, Kronenberg F (2008) Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol 43:347-352
24. Wu J, Chen X, Xie Y, Yamanaka N, Shi S, Wu D, Liu S, Cai G (2005) Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant 20:719-727 (Pubitemid 40520648)
25. Akalin E, Ganeshan SV, Winston J, Muntner P (2008) Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy. Transplantation 86:652-658
26. Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E, Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ (2012) Serum uric acid independently predicts cardiovascular events in advanced nephropathy. Am J Nephrol 36:324-331
27. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood-pressure-independent mechanism. Am J Physiol Renal Physiol 282:F991-F997 (Pubitemid 34654464)
28. Haririan A, Nogueira JM, Zandi-Nejad K, Aiyer R, Hurley H, Cooper M, Klassen DK, Weir MR (2010) The independent association between serum uric acid and graft outcomes after kidney transplantation. Transplantation 89:573-579